Startups
Elucid Vivo provides clinical solutions based on histology & machine learning. We provide solutions for lipid rich necrotic core, atherosclerotic plaque, CTA plaque analysis, risk of heart attack, and stroke.
Overview
Location
United States
Employees
51-200
Total raised
$162M
Investors 4
| Date | Name | Website |
| Sign up to see | Sign up to see | Sign up to see |
| Biovision Ventures | biovision.vc | |
| Angel Physicians Fund | angelphysicians.com | |
| Bioverge | ventures.bioverge.com |
Funding Rounds 3
| Date | Series | Amount | Investors |
| Sign up to see | Sign up to see | Sign up to see | Sign up to see |
| Nov 10, 2023 | Series C round | $80M | |
| Jun 23, 2022 | Series B round | $27M |
Mentions in press and media 16
| Date | Title | Description |
| Sign up to see | Sign up to see | Sign up to see |
| Sep 9, 2026 | Elucid Secures $55M to Revolutionize Heart Diagnostics with AI | Elucid, a Boston-based medtech innovator, just secured $55M in an oversubscribed Series D funding. Total capital now reaches $185M. The company pioneers AI-powered software for precision cardiovascular diagnosis and treatment. Funds will ac... |
| Sep 3, 2026 | Venture Capital & Startup Funding Roundup, September 3, 2026: Base10 Partners, Gradient Ventures, Point72, Y Combinator & More | Today’s funding narrative reinforces that investors are targeting AI-driven solutions across diverse sectors rather than generic “new AI” startups. Major new rounds span from space manufacturing in New Zealand to AI-augmented medical diagno... |
| Sep 3, 2026 | Elucid Scores $55M Series D Round | BOSTON, MA, Elucid has announced the raise of $55 million in an oversubscribed Series D financing. >> Click here for more funding data on Elucid >> To export Elucid funding data to PDF and Excel, click here Elucid, a medical te... |
| Sep 2, 2026 | HiddenLayer Raises $100M to Expand AI Security Platform | HiddenLayer Raises $100M Series B Funding AI security company HiddenLayer has raised $100 million in a Series B financing round. Delta-v Capital led the round. Ten Eleven Ventures, Morgan Stanley, M12 and Booz Allen Ventures also participat... |
| Sep 2, 2026 | Elucid Raises $55M to Expand AI Cardiovascular Diagnostics | Elucid Raises $55M Series D Funding Boston-based medical technology company Elucid has raised $55 million in fresh funding. The company secured the capital through an oversubscribed Series D financing round. The round brings its total fundi... |
| Sep 2, 2026 | Elucid Raises $55M in Seires D Funding | Elucid, a Boston, MA-based provider of AI-powered, clinically validated software to advance precision diagnosis and treatment of cardiovascular disease, raised $55M in Series D funding. Backers included IAG Capital Partners, Elevage Medical... |
| Sep 2, 2026 | Elucid Raises $55M to Expand Non-Invasive Cardiovascular Diagnostic Platform | What You Should Know Boston-based cardiovascular medtech innovator Elucid closed an oversubscribed $55M Series D financing round, bringing its cumulative funding to approximately $185M. The round features participation from a new major, pub... |
| Sep 2, 2026 | Critical Materials Group Raises $10.3M in Seed Funding | Critical Materials Group, an Austin, TX-based provider of a modular energetics production platform, raised $10.3M in Seed funding. The round was led by Overmatch Ventures with participation from Victory Six Advisors and Fulcrum Ventures. Th... |
| Nov 13, 2023 | Elucid collects $80M for AI-powered mapping of blocked arteries | The cardiovascular imaging company Elucid has made it clear they mean to deliver on their promise of artificial intelligence-powered exams to chart the insides of blocked arteries. And now they’ve raised $80 million to do so. Financially sp... |
Show more
Reviews 0
FAQ about Elucid
How much funding has Elucid raised?
Elucid has raised $162M in total across 3 funding rounds.
What funding rounds has Elucid raised?
Parsers VC lists 3 funding rounds of Elucid, among them a Series C round of $80M on Nov 10, 2023 and a Series B round of $27M on Jun 23, 2022.
Who has invested in Elucid?
Parsers VC lists 4 investors of Elucid, among them Biovision Ventures, Angel Physicians Fund and Bioverge.
What has the press written about Elucid?
Parsers VC has collected 16 articles mentioning Elucid, among them “Elucid Secures $55M to Revolutionize Heart Diagnostics with AI” (Sep 9, 2026) and “Venture Capital & Startup Funding Roundup, September 3, 2026: Base10 Partners, Gradient Ventures, Point72, Y Combinator & More” (Sep 3, 2026).
Is Elucid still active?
Yes, Elucid is active; its latest activity on Parsers VC dates from Oct 21, 2026.